;PMID: 1921261
;source_file_810.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:41..116] = [t:41..116]
;2)section:[e:120..162] = [t:120..162]
;3)section:[e:166..240] = [t:166..240]
;4)sentence:[e:244..381] = [t:244..381]
;5)sentence:[e:382..544] = [t:382..544]
;6)sentence:[e:545..664] = [t:545..664]
;7)sentence:[e:665..871] = [t:665..871]
;8)sentence:[e:872..1051] = [t:872..1051]
;9)sentence:[e:1052..1139] = [t:1052..1139]
;10)section:[e:1143..1187] = [t:1143..1187]

;section 0 Span:0..36
;Kobe J Med Sci  1991 Feb;37(1):35-45
(SEC
  (FRAG (NNP:[0..4] Kobe) (NNP:[5..6] J) (NNP:[7..10] Med) (NNP:[11..14] Sci)
        (CD:[16..20] 1991) (CC:[21..28] Feb;37-LRB-) (CD:[28..29] 1)
        (-RRB-:[29..30] -RRB-) (CD:[30..33] :35) (::[33..34] -) (CD:[34..36] 45)))

;sentence 1 Span:41..116
;RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
;[41..44]:gene-rna:"RAS"
;[63..79]:malignancy:"multiple myeloma"
;[92..115]:malignancy:"monoclonal gammopathies"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[41..44] RAS) (NN:[45..49] gene) (NNS:[50..59] mutations))
      (PP-LOC (IN:[60..62] in)
        (NP (JJ:[63..71] multiple) (NN:[72..79] myeloma))))
    (CC:[80..83] and)
    (NP (JJ:[84..91] related)
       (JJ:[92..102] monoclonal) (NNS:[103..115] gammopathies))
    (.:[115..116] .)))

;section 2 Span:120..162
;Matozaki S, Nakagawa T, Nakao Y, Fujita T.
(SEC
  (FRAG (NNP:[120..128] Matozaki) (NNP:[129..131] S,) (NNP:[132..140] Nakagawa)
        (NNP:[141..142] T) (,:[142..143] ,) (NNP:[144..149] Nakao)
        (NNP:[150..151] Y) (,:[151..152] ,) (NNP:[153..159] Fujita)
        (NNP:[160..162] T.)))

;section 3 Span:166..240
;Department of Hematology/Oncology, Hyogo Medical Center for Adult, Akashi.
(SEC
  (FRAG (NNP:[166..176] Department) (IN:[177..179] of)
        (NNP:[180..190] Hematology) (NNP:[190..191] /) (NNP:[191..199] Oncology)
        (,:[199..200] ,) (NNP:[201..206] Hyogo) (NNP:[207..214] Medical)
        (NNP:[215..221] Center) (IN:[222..225] for) (NNP:[226..231] Adult)
        (,:[231..232] ,) (NNP:[233..239] Akashi) (.:[239..240] .)))

;sentence 4 Span:244..381
;The presence of RAS gene mutations in precancerous lesions suggests that they
; participate in the early stages of neoplastic development.
;[260..263]:gene-rna:"RAS"
;[282..302]:malignancy:"precancerous lesions"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[244..247] The) (NN:[248..256] presence))
      (PP (IN:[257..259] of)
        (NP (NN:[260..263] RAS) (NN:[264..268] gene) (NNS:[269..278] mutations)))
      (PP-LOC (IN:[279..281] in)
        (NP (JJ:[282..294] precancerous) (NNS:[295..302] lesions))))
    (VP (VBZ:[303..311] suggests)
      (SBAR (IN:[312..316] that)
        (S
          (NP-SBJ (PRP:[317..321] they))
          (VP (VBP:[323..334] participate)
            (PP-CLR (IN:[335..337] in)
              (NP
                (NP (DT:[338..341] the) (JJ:[342..347] early)
                    (NNS:[348..354] stages))
                (PP (IN:[355..357] of)
                  (NP (JJ:[358..368] neoplastic) (NN:[369..380] development)))))))))
    (.:[380..381] .)))

;sentence 5 Span:382..544
;Furthermore,  neoplastic progression from monoclonal gammopathy of
;undetermined significance  (MGUS) to overt multiple myeloma (MM) have been
;frequently observed.
;[424..474]:malignancy:"monoclonal gammopathy of undetermined significance"
;[477..481]:malignancy:"MGUS"
;[492..508]:malignancy:"multiple myeloma"
;[510..512]:malignancy:"MM"
(SENT
  (S
    (ADVP (RB:[382..393] Furthermore))
    (,:[393..394] ,)
    (NP-SBJ-1
      (NP (JJ:[396..406] neoplastic) (NN:[407..418] progression))
      (PP (IN:[419..423] from)
        (NP
          (NP
            (NP (JJ:[424..434] monoclonal) (NN:[435..445] gammopathy))
            (PP (IN:[446..448] of)
              (NP (JJ:[449..461] undetermined) (NN:[462..474] significance))))
          (NP (-LRB-:[476..477] -LRB-) (NN:[477..481] MGUS)
              (-RRB-:[481..482] -RRB-))))
      (PP (TO:[483..485] to)
        (NP (JJ:[486..491] overt)
          (NML
            (NML (JJ:[492..500] multiple) (NN:[501..508] myeloma))
            (NML (-LRB-:[509..510] -LRB-) (NN:[510..512] MM)
                 (-RRB-:[512..513] -RRB-))))))
    (VP (VBP:[514..518] have)
      (VP (VBN:[519..523] been)
        (ADVP (RB:[524..534] frequently))
        (VP (VBN:[535..543] observed)
          (NP-1 (-NONE-:[543..543] *)))))
    (.:[543..544] .)))

;sentence 6 Span:545..664
;These  observations prompted us to study the pathogenetic role of RAS genes
;in MM and  related monoclonal gammopathies.
;[611..614]:gene-rna:"RAS"
;[624..626]:malignancy:"MM"
;[640..663]:malignancy:"monoclonal gammopathies"
(SENT
  (S
    (NP-SBJ (DT:[545..550] These) (NNS:[552..564] observations))
    (VP (VBD:[565..573] prompted)
      (S
        (NP-SBJ (PRP:[574..576] us))
        (VP (TO:[577..579] to)
          (VP (VB:[580..585] study)
            (NP
              (NP (DT:[586..589] the) (JJ:[590..602] pathogenetic)
                  (NN:[603..607] role))
              (PP (IN:[608..610] of)
                (NP (NN:[611..614] RAS) (NNS:[615..620] genes)))
              (PP (IN:[621..623] in)
                (NP
                  (NP (NN:[624..626] MM))
                  (CC:[627..630] and)
                  (NP (JJ:[632..639] related)
                     (JJ:[640..650] monoclonal) (NNS:[651..663] gammopathies)))))))))
    (.:[663..664] .)))

;sentence 7 Span:665..871
;DNA from 18 patients with monoclonal  gamma-globulinemia including 12 MM were
;investigated for the presence of N- and  K-RAS gene mutations by polymerase
;chain reaction (PCR)/oligonucleotide  hybridization.
;[691..721]:malignancy:"monoclonal  gamma-globulinemia"
;[735..737]:malignancy:"MM"
;[776..778]...[786..789]:gene-rna:"N-"..."RAS"
;[784..789]:gene-rna:"K-RAS"
;[808..818]:gene-protein:"polymerase"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[665..668] DNA))
      (PP (IN:[669..673] from)
        (NP
          (NP (CD:[674..676] 18) (NNS:[677..685] patients))
          (PP (IN:[686..690] with)
            (NP
              (NP (JJ:[691..701] monoclonal) (NN:[703..721] gamma-globulinemia))
              (PP (VBG:[722..731] including)
                (NP (CD:[732..734] 12) (NN:[735..737] MM))))))))
    (VP (VBD:[738..742] were)
      (VP (VBN:[743..755] investigated)
        (NP-1 (-NONE-:[755..755] *))
        (PP (IN:[756..759] for)
          (NP
            (NP (DT:[760..763] the) (NN:[764..772] presence))
            (PP (IN:[773..775] of)
              (NP
                (NP
                  (NML (NN:[776..777] N) (HYPH:[777..778] -)
                    (NML-2 (-NONE-:[778..778] *P*)))
                  (NML-3 (-NONE-:[778..778] *P*)))
                (CC:[779..782] and)
                (NP
                  (NML (NN:[784..785] K) (HYPH:[785..786] -)
                    (NML-2 (NN:[786..789] RAS)))
                  (NML-3 (NN:[790..794] gene) (NNS:[795..804] mutations)))))))
        (PP-MNR (IN:[805..807] by)
          (NP
            (NP
              (NP (NN:[808..818] polymerase) (NN:[819..824] chain)
                  (NN:[825..833] reaction))
              (NP (-LRB-:[834..835] -LRB-) (NN:[835..838] PCR)
                  (-RRB-:[838..839] -RRB-)))
            (SYM:[839..840] /)
            (NP (NN:[840..855] oligonucleotide) (NN:[857..870] hybridization))))))
    (.:[870..871] .)))

;sentence 8 Span:872..1051
;Mutations involving codons 12, 13 or 61 of N-RAS gene were  identified in 3
;of the 12 MM patients, 1 of the solitary plasmacytoma patients  and none of
;the 3 of the MGUS patients.
;[872..881]:variation-event:"Mutations"
;[892..901]:variation-location:"codons 12"
;[892..898]...[909..911]:variation-location:"codons"..."61"
;[892..898]...[903..905]:variation-location:"codons"..."13"
;[915..920]:gene-rna:"N-RAS"
;[958..960]:malignancy:"MM"
;[980..1001]:malignancy:"solitary plasmacytoma"
;[1037..1041]:malignancy:"MGUS"
(SENT
  (S
    (NP-SBJ-2
      (NP (NNS:[872..881] Mutations))
      (VP (VBG:[882..891] involving)
        (NP
          (NP
            (NP
              (NML-1 (NNS:[892..898] codons))
              (CD:[899..901] 12))
            (,:[901..902] ,)
            (NP
              (NML-1 (-NONE-:[902..902] *P*))
              (CD:[903..905] 13))
            (CC:[906..908] or)
            (NP
              (NML-1 (-NONE-:[908..908] *P*))
              (CD:[909..911] 61)))
          (PP (IN:[912..914] of)
            (NP (NN:[915..920] N-RAS) (NN:[921..925] gene))))))
    (VP (VBD:[926..930] were)
      (VP (VBN:[932..942] identified)
        (NP-2 (-NONE-:[942..942] *))
        (PP-LOC (IN:[943..945] in)
          (NP
            (NP
              (NP (CD:[946..947] 3))
              (PP (IN:[948..950] of)
                (NP (DT:[951..954] the) (CD:[955..957] 12) (NN:[958..960] MM)
                    (NNS:[961..969] patients))))
            (,:[969..970] ,)
            (NP
              (NP (CD:[971..972] 1))
              (PP (IN:[973..975] of)
                (NP (DT:[976..979] the)
                  (NML (JJ:[980..988] solitary) (NN:[989..1001] plasmacytoma))
                  (NNS:[1002..1010] patients))))
            (CC:[1012..1015] and)
            (NP
              (NP (NN:[1016..1020] none))
              (PP (IN:[1021..1023] of)
                (NP
                  (NP (DT:[1024..1027] the) (CD:[1028..1029] 3))
                  (PP (IN:[1030..1032] of)
                    (NP (DT:[1033..1036] the) (NN:[1037..1041] MGUS)
                        (NNS:[1042..1050] patients))))))))))
    (.:[1050..1051] .)))

;sentence 9 Span:1052..1139
;In the case of plasmacytoma, RAS  mutations were detected in his bone marrow
;specimens.
;[1067..1079]:malignancy:"plasmacytoma"
;[1081..1084]:gene-rna:"RAS"
(SENT
  (S
    (PP (IN:[1052..1054] In)
      (NP
        (NP (DT:[1055..1058] the) (NN:[1059..1063] case))
        (PP (IN:[1064..1066] of)
          (NP (NN:[1067..1079] plasmacytoma)))))
    (,:[1079..1080] ,)
    (NP-SBJ-1 (NN:[1081..1084] RAS) (NNS:[1086..1095] mutations))
    (VP (VBD:[1096..1100] were)
      (VP (VBN:[1101..1109] detected)
        (NP-1 (-NONE-:[1109..1109] *))
        (PP-LOC (IN:[1110..1112] in)
          (NP (PRP$:[1113..1116] his)
            (NML (NN:[1117..1121] bone) (NN:[1122..1128] marrow))
            (NNS:[1129..1138] specimens)))))
    (.:[1138..1139] .)))

;section 10 Span:1143..1187
;PMID: 1921261 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1143..1147] PMID) (::[1147..1148] :) (CD:[1149..1156] 1921261)
        (NN:[1157..1158] -LSB-) (NNP:[1158..1164] PubMed) (::[1165..1166] -)
        (NN:[1167..1174] indexed) (IN:[1175..1178] for)
        (NNP:[1179..1187] MEDLINE-RSB-)))
